Chronic THC impaired working memory in monkeys but did not change dopamine D2/D3 receptor levels

What the researchers found

Six adult male rhesus monkeys were tested on cognitive tasks using touchscreen tests (CANTAB) before and during 12 weeks of daily THC (1.0-2.0 mg/kg).

Acute THC impaired cognitive performance in a task-specific manner and reduced food-motivated responding and body temperature.

During chronic treatment, THC produced persistent residual impairment only to working memory, measured 22 hours after each dose. Other cognitive domains showed tolerance development.

Working memory recovered to baseline within two weeks of abstinence.

PET imaging comparing four THC-treated monkeys to four drug-naive controls found no difference in dopamine D2/D3 receptor availability, suggesting the cognitive effects were not driven by changes in dopamine receptor density.

The authors suggested that interventions targeting working memory could improve treatment outcomes for cannabis use disorder.

Why it matters

This primate study provides a controlled look at how chronic THC affects cognition over time, something impossible to study as rigorously in humans. The finding that working memory was selectively vulnerable while other functions showed tolerance is clinically relevant for understanding cannabis use disorder.

The numbers in context

6 monkeys, 12 weeks of daily THC (1.0-2.0 mg/kg s.c.). Working memory was the only domain with persistent residual impairment at 22 hours post-dose. Recovery occurred within 2 weeks of abstinence. No significant difference in D2/D3 receptor availability between 4 THC-treated and 4 control monkeys.

How the study worked

Primate study with six rhesus monkeys. Acute THC dose-response testing followed by 12 weeks of daily chronic THC. Cognitive assessment via CANTAB touchscreen battery. Dopamine D2/D3 receptor availability measured by PET with [11C]-raclopride in a subgroup (4 THC-treated vs 4 controls).

What this study cannot tell us

Very small sample size (6 monkeys, 4 per group for PET). Only male monkeys studied. THC doses may not map directly to human consumption patterns. D2/D3 receptors are one component of the dopamine system; other aspects (release, synthesis, D1 receptors) were not measured.

How to read the evidence

Moderate. Primate model with controlled conditions and validated cognitive measures, but very small sample limits statistical confidence.

When this study was published

Published in 2018. Subsequent research has continued exploring the relationship between chronic cannabis use, cognition, and dopamine signaling.

The bigger picture

The selective vulnerability of working memory to chronic THC, combined with its recovery after abstinence, suggests that cannabis-related cognitive impairment may be reversible. The lack of D2/D3 receptor changes challenges the theory that cannabis impairs cognition through dopaminergic mechanisms.

Questions still open

• What neurochemical mechanism drives the selective working memory impairment if not D2/D3 receptors? Would longer THC exposure lead to slower recovery? Do these findings differ in female primates?

Common questions

Read the original research

Chronic Δ9-THC in Rhesus Monkeys: Effects on Cognitive Performance and Dopamine D2/D3 Receptor Availability.

The Journal of pharmacology and experimental therapeutics, 364(2), 300-310

Citation

John, William S; Martin, Thomas J; Solingapuram Sai, Kiran Kumar; Nader, Susan H; Gage, H Donald; Mintz, Akiva; Nader, Michael A. (2018). Chronic Δ9-THC in Rhesus Monkeys: Effects on Cognitive Performance and Dopamine D2/D3 Receptor Availability.. The Journal of pharmacology and experimental therapeutics, 364(2), 300-310. https://doi.org/10.1124/jpet.117.244194

Explore the wider topic

• How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
• The Anandamide Connection: Your Body's Natural Bliss Molecule
• How Long for Cannabinoid Receptors to Return to Normal
• Physical vs Psychological Cannabis Dependence: What Science Actually Shows
• Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
• The Gap Between Cannabis Perception and Science: Why What We Believe Outpaces What We Know
• Cannabis Use Disorder: Am I Addicted? Self-Assessment Guide
• Why Can't I Enjoy Anything Without Weed? The Science Behind It
• Cross-Addiction After Quitting Weed: When One Habit Replaces Another
• Dopamine Recovery After Quitting Weed: What the Science Says
• The Endocannabinoid System Explained Simply: What It Does and Why It Matters
• Your Endocannabinoid System Explained: Why Withdrawal Happens
• Is Weed Addictive? What the Research Actually Shows
• Is Cannabis Addictive? What the DSM-5 and Brain Science Say
• Your Nervous System After Quitting Weed: Fight or Flight
• Quitting Weed and Alcohol Together: What to Know About Dual Cessation
• Is Rehab Necessary for Weed? An Honest Assessment
• Signs You May Have Cannabis Use Disorder: An Honest Self-Assessment
• Using Weed Under 18: What It Does to Your Developing Brain
• What THC Does to Your Brain: Why Withdrawal Happens
• THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
• Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
• Weed and Memory: What the Science Says About THC and Your Hippocampus
• Weed and Motivation: Is Amotivational Syndrome Real?
• Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
• How Weed Rewires Your Reward System (And How to Reset It)
• Weed Vape Pen Addiction: Why Vaping Makes It Harder to Quit
• Cannabis Effects and Experience: The Science Behind Your High
• Why Am I More Creative When I'm High? THC and Divergent Thinking
• THC and Discipline: Does Daily Use Erode Willpower
• THC and Creative Work: Artists, Musicians, and Writers on Cannabis